Key Drivers
- Margin improvement
- Elevated leverage
- Acquisition dependence
AIAI Summary
JHX is now an AZEK integration and deleveraging execution story: investors should demand visible delivery of FY27 cost synergies, sustained free cash flow, and progress toward sub-2.0x leverage before paying its premium valuation, especially given cyclical housing exposure and weak technical momentum.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Margin improvement
- •Elevated leverage
- •Acquisition dependence
JHX shows improving margins and cash generation, but high leverage, acquisition-driven borrowing, modest returns, and expensive valuation warrant caution.
Price Behavior
Key Price Behavior Insights:
- •Persistent selling
- •Oversold momentum
- •Critical support
JHX is in a strong downtrend over the last month, with oversold RSI suggesting rebound potential but $25.80–$26.00 support failure could extend losses unless price reclaims $28.90.
Selling accelerated after 2026-09-10
Sentiment & News
Key News Insights:
- •European sale
- •Growth refocus
- •Cautious outlook
James Hardie's €840m Fermacell divestiture sharpens its higher-growth focus, but cautious Investor Day sentiment may pressure near-term shares.
The divestiture supports long-term strategic positioning, though near-term investor skepticism may weigh on JHX
Similar Companies in Basic Materials
Other companies in the same sector with AI ratings